Dublin, OH – According to filings with the U.S. Securities and Exchange Commission, Monitored Therapeutics is raising $5,000,000.00 in new funding. Sources indicate as part of senior management President, Michael Taylor played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Monitored Therapeutics

Monitored Therapeutics Inc. (MTI) is Respiratory Telehealthcare Company focused on COPD, Asthma, Lung Transplant, and Cystic Fibrosis with four proprietary products – GoSpiro Home Spirometer, GoHome Patient Health Monitor, GoClinic, GoECG and the MTI CarePortal. MTI extends Access to Care to the patient and provider through a standardized platform, increasing Patient Engagement, Drug Adherence and Quality of Life while decreasing overall healthcare costs by keeping patients in their homes and out of the hospital..

To learn more about Monitored Therapeutics, visit http://monitoredrx.com/

Contact:
Michael Taylor, President
614-761-3555
https://www.linkedin.com/in/michael-taylor-3b86618/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved